Cargando…
A paradigm shift in cell-free approach: the emerging role of MSCs-derived exosomes in regenerative medicine
Recently, mesenchymal stem/stromal cells (MSCs) due to their pro-angiogenic, anti-apoptotic, and immunoregulatory competencies along with fewer ethical issues are presented as a rational strategy for regenerative medicine. Current reports have signified that the pleiotropic effects of MSCs are not r...
Autores principales: | Moghadasi, Soudeh, Elveny, Marischa, Rahman, Heshu Sulaiman, Suksatan, Wanich, Jalil, Abduladheem Turki, Abdelbasset, Walid Kamal, Yumashev, Alexei Valerievich, Shariatzadeh, Siavash, Motavalli, Roza, Behzad, Farahnaz, Marofi, Faroogh, Hassanzadeh, Ali, Pathak, Yashwant, Jarahian, Mostafa |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8273572/ https://www.ncbi.nlm.nih.gov/pubmed/34253242 http://dx.doi.org/10.1186/s12967-021-02980-6 |
Ejemplares similares
-
CAR-engineered NK cells; a promising therapeutic option for treatment of hematological malignancies
por: Marofi, Faroogh, et al.
Publicado: (2021) -
CAR‐NK cell in cancer immunotherapy; A promising frontier
por: Marofi, Faroogh, et al.
Publicado: (2021) -
A Deep Insight Into CAR-T Cell Therapy in Non-Hodgkin Lymphoma: Application, Opportunities, and Future Directions
por: Marofi, Faroogh, et al.
Publicado: (2021) -
Harnessing TRAIL-Induced Apoptosis Pathway for Cancer Immunotherapy and Associated Challenges
por: Razeghian, Ehsan, et al.
Publicado: (2021) -
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism
por: Marofi, Faroogh, et al.
Publicado: (2021)